Search Results

Most of them are small molecules capable of going through the BBB , and since their targets are on the Molecules. 2023 Dec 15;28(24):8107. doi: 10.3390/molecules28248107

Collaborative efforts aim to accelerate and improve the prediction of first-in-class small molecule agonists

continued study of their function and mechanism of action, there is a greater understanding of how effector molecules

GPCR dimers are very attractive molecular entities since they have been found to drive biased signalling

Pharmacological chaperones are cell-permeant small molecules that engage nascent mutant GPCRs in the mutant follicle-stimulating hormone receptors (FSHRs) with poor cell surface expression using a small-molecule

Adhesion GPCR with Multiple Roles in Human Diseases, Current Status and Future Perspective Structural and Molecular

Good molecules can fail quietly at this stage —not because they’re weak, but because they’re too strong If you’re not designing with persistent enzyme interactions in mind, you’re building risk into your molecule

former colleagues and their description of the company was very intriguing: a biology focused, small molecule

class A GPCR-Gi complex structures is observed in CX3CR1, which may correlate with three cholesterol molecules

Overall, our findings supported GPR108 as a promising therapeutic target of cancer, and provided a small molecule

This 28-day trial will test the pharmacokinetics and safety profile of Inversago’s lead molecule, INV

Therefore, the ascaroside signaling system provides a unique example of a signaling molecule that regulates C. elegans secretes a family of small-molecule pheromones called ascarosides, which serve various functions

Keep pushing the boundaries, because your work moves molecules and medicine forward.   

, we provide a systematic analysis of the currently available GPCR structures in complex with small-molecule

PKA facilitates the actions of hormones, neurotransmitters and other signaling molecules that bind G-protein

Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules

So far, numerous therapeutics targeting GPCRs have been developed, with a focus on small molecules and

structure-based technology has passed a key test, in enabling the discovery of orally available small molecules

They include small molecules that conditionally modulate proteins in their functional state; three-dimensional

studied by protein mapping using the FTMap server, which determines the clustering of small organic probe molecules

approximately 850 GPCRs) has been successfully drugged, and obtaining highly potent and selective small molecules

phosphorylation sites are required for recruitment of the adaptor protein STAM1 (signal-transducing adaptor molecule

The development of new CB2-related pharmacological and genetic tools, including the first small molecule

This talk gave a general idea of what goes into designing small molecule drugs, using state-of-the-art

parameters of serotonin1A receptors in normal cells are consistent with models describing the diffusion of molecules

Pharmacological targeting of cGAS/STING-YAP signaling by both a small-molecule STING agonist, SR-717,

this accuracy to synthetic compounds, limiting its utility in drug discovery involving novel drug-like molecules

Ambiguous Decision Gates: Molecules advance or stall based on vibes, not criteria.

Here, we describe new tools, referred to as "SynTAMs" for synaptic targeting molecules, that enable localized

essential in biology and understanding how cells integrate signals from a variety of information-coding molecules